Previous studies on AR mutations have either simply reported the presence of specific mutations in prostate cancer biopsies or analyzed a select few examples using incompatible methodology, thus precluding meaningful comparison of the consequences of the mutations. This evidence concerns the gene AR and prostate cancer.